Penn Medicine Abramson Cancer Center


 

Updates on MCL: Ibrutinib + Ven, Len + Rituximab, 1L Sequential Immunochemotherapy, LOXO-305, Lisocabtagene Maraleucel

78 views
July 15, 2021
0 Comments
Login to view comments. Click here to Login
New Therapies and Current Patient Management of Lymphomas